logo
logo
Sign in

The Global Allergic Asthma Therapeutics Market is Driven by Rising Prevalence Of Allergic Asthma Disorders

avatar
ashwini bakhade
The Global Allergic Asthma Therapeutics Market is Driven by Rising Prevalence Of Allergic Asthma Disorders

 Allergic asthma therapeutics aims to treat patients suffering from allergic asthma disorders through anti-inflammatory and bronchodilator drugs. Allergic asthma refers to a type of asthma caused by an allergic reaction to inhaled allergens such as dust mites, pollen, pet dander, or mold. The common symptoms include chest tightness, wheezing, cough and shortness of breath. The global demand for these therapeutics has been rising with increasing cases of allergic asthma worldwide due to factors such as genetic predisposition and exposure to allergens and air pollution. The therapeutics provide fast relief from asthma exacerbations and improve the quality of life for patients.


The global Allergic Asthma Therapeutics Market is estimated to be valued at US$ 8.37 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.


Market key trends:

The increasing research pipelines for novel biologics and targeted therapies presents one of the major trends in the allergic asthma therapeutics market. Currently, monoclonal antibodies targeting immunoglobulin E (IgE), interleukin-4 (IL-4), interleukin-5 (IL-5) and their receptors have shown promising results in clinical trials for treating allergic asthma. Companies are also investing in developing therapies targeting cytokines like IL-33 and thymic stromal lymphopoietin (TSLP) involved in allergic inflammation. Such novel targeted therapies are expected to provide improved efficacy over existing drugs with lesser side effects.

Porter's Analysis

Threat of new entrants: The risk of new players entering the allergic asthma therapeutics market is moderate as considerable capital investment is required to develop new treatment alternatives and compete with established brands. However, development of novel treatment options by biotech companies provide opportunities.

Bargaining power of buyers: The bargaining power of buyers in the form of patients and healthcare facilities is moderate. Asthma being a chronic respiratory condition offers sustained revenues to pharmaceutical companies.

Bargaining power of suppliers: Suppliers of active pharmaceutical ingredients and contract manufacturing organizations have moderate bargaining power given the intellectual property and regulatory requirements around drug development.

Threat of new substitutes: Threat from substitute treatment options is moderate as novel biologics and combination therapies continue to expand therapeutic choices for allergic asthma.

Competitive rivalry: The allergic asthma therapeutics market witnesses high competition due to presence of large pharmaceutical companies and steady product pipeline of biologics.


Key Takeaways

The global allergic asthma therapeutics market is expected to witness high growth over the forecast period owing to rising asthma prevalence globally.

North America is expected to dominate the market over the forecast period owing to high awareness regarding asthma treatment options and robust healthcare infrastructure in the region.

Key players operating in the allergic asthma therapeutics market are Ansarada Pty Ltd., Brainloop AG (Diligent Corporation), CapLinked, Citrix Systems Inc., Datasite Global Corporation, DealRoom Inc., EthosData, Firmex Inc, FORDATA sp. z o.o., iDeals Solutions Group, Intralinks Holdings Inc. (SS&C Technologies), SecureDocs Inc., ShareVault (Pandesa Corporation) and SmartRoom (BMC Group).

For More details on the topic:

https://www.marketwebjournal.com/allergic-asthma-therapeutics-market-trends-size-and-share-analysis/


collect
0
avatar
ashwini bakhade
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more